Organisation paid for research Program year 2025 Source: CMS Open Payments

Mass General Brigham

Neither a doctor nor a teaching hospital

Research payments

$448,576

11 payments

Through program year 2025, Mass General Brigham is reported as receiving $448,576 in research payments, across 11 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$162,125	3
2024	Research	$241,894	3
2023	Research	$2,594	4
2022	Research	$41,963	1

Breakdown

Who paid Research payments · program years 2022–2025

Hologic Inc $132,758 1 payment
Alcresta Therapeutics, Inc. $119,627 1 payment
Boehringer Ingelheim Pharmaceuticals, Inc. $99,636 1 payment
Mannkind Corporation $42,498 2 payments
Bayer HealthCare Pharmaceuticals Inc. $41,963 1 payment
AstraZeneca UK Limited $9,500 1 payment
Octapharma USA, Inc. $2,594 4 payments

Studies the money was for Research payments · program years 2022–2025

GAID 2.0 Research Collab $132,758 1 payment
2024P002758 $119,627 1 payment
US Ecr_2021_00003125 $99,636 1 payment
Icon-1 Phase 3 Study of the Efficacy and Safety of Treatment With Mnkd-101, Clofazamine Inhalation Suspension $42,498 2 payments
Piazza - IIR-US-00218 $41,963 1 payment
A Multicenter Randomized Double blind Placebo controlled Phase III Study to Evaluate the Efficacy and Safety of Anifrolumab in Adults with Chronic and/or Subacute Cutaneous Lupus Erythematosus and Refractory and/or Intolerant to Antimalarial Therapy $9,500 1 payment
Ngam-13 $1,394 1 payment
Ngam13 $1,200 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.